Teaching information for CMA

If you are interested in using CMA to teach a class in meta-analysis, please submit your e-mail here for more information.

Valid e-mail is required.

Please provide the university / organization, the approximate class size, and the course duration below.

Details are required.

"Comprehensive Meta‐Analysis is, in my view, the best meta‐analysis software on the market and a "must have" for any meta‐analyst. Before I used this software, I was convinced that specialized metaanalysis software was not necessary at all. At that time, I used my own Excel spreadsheets and SPSS to run meta‐analysis. In fact, I only tried CMA because I needed a way to make forest plots. Once I tried it, however, I was sold. I could not believe how user friendly it was and how much it could do. Suddenly not only was meta‐analysis more efficient, but, more importantly, I could run all types of analyses that previously were not available with the software I had been using. I have since used the program to conduct and publish several meta‐analyses. Given how great the program is, I require it when I teach my graduate meta‐analysis seminar. Students always seem surprised when they see how easy it is to use, as this is certainly not the norm in statistical software. Thus, our graduate students seem to greatly value CMA as a key resource for conducting meta‐analysis."

Seth M. Noar, Ph.D. - Professor, Hussman School of Journalism and Media, University of North Carolina at Chapel Hill


"The meta‐analysis program is easy to use and provides me with information that would be hard to get by any other means. I analyze a lot of data and, believe it or not, use the meta‐analysis program every day. I am not a statistician, but the results I produce have routinely been verified by statistical consultants costing large amounts for their confirmatory analyses. Without verification, I have used the results to make important decisions regarding a potential billion dollar a year product. At night I wonder, “What would I have done without this great program.”"

Louis Fabre MD, PhD - Chairman, Fabre‐Kramer Pharmaceuticals Inc.